Tag: Novo Nordisk A/S

Novo Nordisk’s explosive Wegovy pill launch draws a new wave of patients into GLP-1 weight loss treatment

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

U.S. executives, from Apple to Eli Lilly, revamp their push into the world’s second-largest economy at the China Development Forum

Danone to buy protein shake maker Huel as health nutrition craze drives demand shift

India is launching cheap, weight-loss drugs and Novo Nordisk is betting on its brands to stay on top